{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T20:56:35Z","timestamp":1793048195424,"version":"4.5.0"},"reference-count":261,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T00:00:00Z","timestamp":1786665600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007957","name":"Chongqing Municipal Education Commission","doi-asserted-by":"publisher","award":["KJZD-K202501108"],"award-info":[{"award-number":["KJZD-K202501108"]}],"id":[{"id":"10.13039\/501100007957","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004867","name":"Chongqing University of Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004867","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22307012"],"award-info":[{"award-number":["22307012"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012458","name":"Chongqing Basic Science and Advanced Technology Research Program","doi-asserted-by":"publisher","award":["2024CCZ096"],"award-info":[{"award-number":["2024CCZ096"]}],"id":[{"id":"10.13039\/501100012458","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Materials Today Bio"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.mtbio.2026.103568","type":"journal-article","created":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T23:35:01Z","timestamp":1787096101000},"page":"103568","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Overcoming hepatic tropism: Precision engineering of lipid nanoparticles for extrahepatic RNA delivery"],"prefix":"10.1016","volume":"40","author":[{"given":"Yu","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunyuan","family":"Gan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shili","family":"Nie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingheng","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xintong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-6395-9235","authenticated-orcid":false,"given":"Yaqin","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mtbio.2026.103568_bib1","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.omtn.2017.06.005","article-title":"Therapeutic miRNA and siRNA: moving from bench to clinic as next generation medicine","volume":"8","author":"Chakraborty","year":"2017","journal-title":"Mol. Ther. Nucleic Acids"},{"issue":"3","key":"10.1016\/j.mtbio.2026.103568_bib2","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1172\/JCI84424","article-title":"Targeting noncoding RNAs in disease","volume":"127","author":"Adams","year":"2017","journal-title":"J. Clin. Investig."},{"issue":"4","key":"10.1016\/j.mtbio.2026.103568_bib3","doi-asserted-by":"crossref","first-page":"3004","DOI":"10.1002\/jcp.26055","article-title":"MicroRNA: a novel target of curcumin in cancer therapy","volume":"233","author":"Mirzaei","year":"2018","journal-title":"J. Cell. Physiol."},{"issue":"1","key":"10.1016\/j.mtbio.2026.103568_bib4","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/nrm.2016.132","article-title":"Post-transcriptional gene regulation by mRNA modifications","volume":"18","author":"Zhao","year":"2017","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"1","key":"10.1016\/j.mtbio.2026.103568_bib5","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s13073-017-0450-0","article-title":"Advances in the delivery of RNA therapeutics: from concept to clinical reality","volume":"9","author":"Kaczmarek","year":"2017","journal-title":"Genome Med."},{"key":"10.1016\/j.mtbio.2026.103568_bib6","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.jconrel.2024.03.056","article-title":"mRNA therapies: pioneering a new era in rare genetic disease treatment","volume":"369","author":"Shen","year":"2024","journal-title":"J. Contr. Release"},{"issue":"1","key":"10.1016\/j.mtbio.2026.103568_bib7","doi-asserted-by":"crossref","first-page":"281","DOI":"10.7150\/thno.35568","article-title":"RNA nanotechnology-mediated cancer immunotherapy","volume":"10","author":"Lin","year":"2020","journal-title":"Theranostics"},{"issue":"4","key":"10.1016\/j.mtbio.2026.103568_bib8","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.ymthe.2019.02.012","article-title":"Delivering the messenger: advances in technologies for therapeutic mRNA delivery","volume":"27","author":"Kowalski","year":"2019","journal-title":"Mol. Ther."},{"issue":"1","key":"10.1016\/j.mtbio.2026.103568_bib9","doi-asserted-by":"crossref","first-page":"7233","DOI":"10.1038\/s41467-021-27493-0","article-title":"An ionizable lipid toolbox for RNA delivery","volume":"12","author":"Han","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.mtbio.2026.103568_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114238","article-title":"Why nanoparticles prefer liver macrophage cell uptake in vivo","volume":"185","author":"Ngo","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"1","key":"10.1016\/j.mtbio.2026.103568_bib11","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s12951-022-01309-9","article-title":"Lipid based nanoparticles as a novel treatment modality for hepatocellular carcinoma: a comprehensive review on targeting and recent advances","volume":"20","author":"Mahmoud","year":"2022","journal-title":"J. Nanobiotechnol."},{"issue":"6","key":"10.1016\/j.mtbio.2026.103568_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2024.109804","article-title":"Optimized lipid nanoparticles (LNPs) for organ-selective nucleic acids delivery in vivo","volume":"27","author":"Zhang","year":"2024","journal-title":"iScience"},{"key":"10.1016\/j.mtbio.2026.103568_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120586","article-title":"mRNA-lipid nanoparticle COVID-19 vaccines: structure and stability","volume":"601","author":"Schoenmaker","year":"2021","journal-title":"Int J Pharm"},{"issue":"1","key":"10.1016\/j.mtbio.2026.103568_bib14","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/s41563-025-02331-6","article-title":"Peptide codes for organ-selective mRNA delivery","volume":"25","author":"Chang","year":"2026","journal-title":"Nat. Mater."},{"issue":"7","key":"10.1016\/j.mtbio.2026.103568_bib15","doi-asserted-by":"crossref","DOI":"10.3390\/ph15070897","article-title":"The future of tissue-targeted lipid nanoparticle-mediated nucleic acid delivery","volume":"15","author":"Kularatne","year":"2022","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.mtbio.2026.103568_bib16","article-title":"Advances in nano drug delivery systems for enhanced efficacy of emodin in cancer therapy","volume":"X 9","author":"Ai","year":"2025","journal-title":"Int J Pharm"},{"key":"10.1016\/j.mtbio.2026.103568_bib17","doi-asserted-by":"crossref","first-page":"8831","DOI":"10.2147\/IJN.S474888","article-title":"Nanoparticles as a novel platform for cardiovascular disease diagnosis and therapy","volume":"19","author":"Tang","year":"2024","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.mtbio.2026.103568_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2023.114965","article-title":"Recent advances and prospects for lipid-based nanoparticles as drug carriers in the treatment of human retinal diseases","volume":"199","author":"Zeng","year":"2023","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"3","key":"10.1016\/j.mtbio.2026.103568_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtm.2025.101518","article-title":"Rational design of lipid nanoparticles for enabling gene therapies","volume":"33","author":"Brimacombe","year":"2025","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.mtbio.2026.103568_bib20","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.jconrel.2024.04.039","article-title":"Emerging advances in delivery systems for mRNA cancer vaccines","volume":"370","author":"Jiang","year":"2024","journal-title":"J. Contr. Release"},{"issue":"4","key":"10.1016\/j.mtbio.2026.103568_bib21","doi-asserted-by":"crossref","first-page":"6709","DOI":"10.1021\/acsnano.0c10064","article-title":"Apolipoprotein E binding drives structural and compositional rearrangement of mRNA-Containing lipid nanoparticles","volume":"15","author":"Sebastiani","year":"2021","journal-title":"ACS Nano"},{"issue":"11","key":"10.1016\/j.mtbio.2026.103568_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.cclet.2025.110849","article-title":"Nucleic acid delivery by lipid nanoparticles for organ targeting","volume":"36","author":"Guo","year":"2025","journal-title":"Chin. Chem. Lett."},{"issue":"1","key":"10.1016\/j.mtbio.2026.103568_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtm.2025.101436","article-title":"Why do lipid nanoparticles target the liver? Understanding of biodistribution and liver-specific tropism","volume":"33","author":"Hosseini-Kharat","year":"2025","journal-title":"Mol. Ther. Methods Clin. Dev."},{"issue":"24","key":"10.1016\/j.mtbio.2026.103568_bib24","doi-asserted-by":"crossref","first-page":"10025","DOI":"10.1021\/acs.nanolett.2c03741","article-title":"The extent to which lipid nanoparticles require apolipoprotein E and low-density lipoprotein receptor for delivery changes with ionizable lipid structure","volume":"22","author":"Paunovska","year":"2022","journal-title":"Nano Lett."},{"key":"10.1016\/j.mtbio.2026.103568_bib26","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.addr.2020.06.026","article-title":"Lipid nanoparticle technology for therapeutic gene regulation in the liver","volume":"159","author":"Witzigmann","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"1","key":"10.1016\/j.mtbio.2026.103568_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1476-5926-1-1","article-title":"Structural and functional aspects of liver sinusoidal endothelial cell fenestrae: a review","volume":"1","author":"Braet","year":"2002","journal-title":"Comp. Hepatol."},{"issue":"11","key":"10.1016\/j.mtbio.2026.103568_bib27","article-title":"Understanding nanomaterial-liver interactions to facilitate the development of safer nanoapplications","volume":"34","author":"Li","year":"2022","journal-title":"Adv. Mater."},{"issue":"17\u201318","key":"10.1016\/j.mtbio.2026.103568_bib28","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1089\/hum.2024.106","article-title":"Lipid nanoparticles for nucleic acid delivery beyond the liver","volume":"35","author":"Saber","year":"2024","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.mtbio.2026.103568_bib29","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2025.1473863","article-title":"Hepatobiliary organoid research: the progress and applications","volume":"16","author":"Zou","year":"2025","journal-title":"Front. Pharmacol."},{"issue":"44","key":"10.1016\/j.mtbio.2026.103568_bib30","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202401445","article-title":"Tuning lipid nanoparticles for RNA delivery to extrahepatic organs","volume":"36","author":"Song","year":"2024","journal-title":"Adv. Mater."},{"key":"10.1016\/j.mtbio.2026.103568_bib31","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1743-8977-4-10","article-title":"Kupffer cells are central in the removal of nanoparticles from the organism","volume":"4","author":"Sadauskas","year":"2007","journal-title":"Part. Fibre Toxicol."},{"issue":"10","key":"10.1016\/j.mtbio.2026.103568_bib32","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.3390\/pharmaceutics17101309","article-title":"Physiological barriers to nucleic acid therapeutics and engineering strategies for lipid nanoparticle design, optimization, and clinical translation","volume":"17","author":"Kim","year":"2025","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/j.mtbio.2026.103568_bib33","doi-asserted-by":"crossref","DOI":"10.1002\/bmm2.12116","article-title":"Principles of lipid nanoparticle design for mRNA delivery","volume":"3","author":"Zhang","year":"2025","journal-title":"BMEMat"},{"issue":"2","key":"10.1016\/j.mtbio.2026.103568_bib34","article-title":"From structural design to delivery: mRNA therapeutics for cancer immunotherapy","volume":"4","author":"Zhou","year":"2024","journal-title":"Explorations"},{"issue":"11","key":"10.1016\/j.mtbio.2026.103568_bib35","doi-asserted-by":"crossref","first-page":"16982","DOI":"10.1021\/acsnano.1c04996","article-title":"Lipid nanoparticles\u2500from liposomes to mRNA vaccine delivery, a landscape of research diversity and advancement","volume":"15","author":"Tenchov","year":"2021","journal-title":"ACS Nano"},{"issue":"1","key":"10.1016\/j.mtbio.2026.103568_bib36","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s11095-022-03460-2","article-title":"Structure and function of cationic and ionizable lipids for nucleic acid delivery","volume":"40","author":"Sun","year":"2023","journal-title":"Pharm. Res."},{"key":"10.1016\/j.mtbio.2026.103568_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.113945","article-title":"Impact of ionizable lipid type on the pharmacokinetics and biodistribution of mRNA-lipid nanoparticles after intravenous and subcutaneous injection","volume":"384","author":"Ren","year":"2025","journal-title":"J. Contr. Release"},{"issue":"11","key":"10.1016\/j.mtbio.2026.103568_bib38","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2307800120","article-title":"Endosomal escape: a bottleneck for LNP-Mediated therapeutics","volume":"121","author":"Chatterjee","year":"2024","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.mtbio.2026.103568_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114416","article-title":"The role of lipid components in lipid nanoparticles for vaccines and gene therapy","volume":"188","author":"Hald Albertsen","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"1","key":"10.1016\/j.mtbio.2026.103568_bib44","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1038\/s41467-020-14527-2","article-title":"Naturally-occurring cholesterol analogues in lipid nanoparticles induce polymorphic shape and enhance intracellular delivery of mRNA","volume":"11","author":"Patel","year":"2020","journal-title":"Nat. Commun."},{"issue":"22","key":"10.1016\/j.mtbio.2026.103568_bib40","doi-asserted-by":"crossref","first-page":"6743","DOI":"10.1021\/acs.nanolett.4c01458","article-title":"Helper lipid-enhanced mRNA delivery for treating metabolic dysfunction-associated fatty liver disease","volume":"24","author":"Guo","year":"2024","journal-title":"Nano Lett."},{"key":"10.1016\/j.mtbio.2026.103568_bib41","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.addr.2016.01.022","article-title":"The role of helper lipids in lipid nanoparticles (LNPs) designed for oligonucleotide delivery","volume":"99","author":"Cheng","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.mtbio.2026.103568_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbpa.2024.102499","article-title":"Rational design of lipid nanoparticles: overcoming physiological barriers for selective intracellular mRNA delivery","volume":"81","author":"Zhao","year":"2024","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.mtbio.2026.103568_bib43","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.addr.2020.06.002","article-title":"Lipid nanoparticles for nucleic acid delivery: current perspectives","volume":"154-155","author":"Samaridou","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"4","key":"10.1016\/j.mtbio.2026.103568_bib45","doi-asserted-by":"crossref","DOI":"10.3390\/nano10040787","article-title":"Stealth coating of nanoparticles in drug-delivery systems","volume":"10","author":"Fam","year":"2020","journal-title":"Nanomaterials"},{"issue":"2","key":"10.1016\/j.mtbio.2026.103568_bib46","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15020597","article-title":"Effect of PEG anchor and serum on lipid nanoparticles: development of a nanoparticles tracking method","volume":"15","author":"Berger","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.mtbio.2026.103568_bib47","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.addr.2015.09.012","article-title":"PEGylation as a strategy for improving nanoparticle-based drug and gene delivery","volume":"99","author":"Suk","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.mtbio.2026.103568_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2022.121415","article-title":"Branched PEG-modification: a new strategy for nanocarriers to evade of the accelerated blood clearance phenomenon and enhance anti-tumor efficacy","volume":"283","author":"Liu","year":"2022","journal-title":"Biomaterials"},{"issue":"40","key":"10.1016\/j.mtbio.2026.103568_bib49","doi-asserted-by":"crossref","first-page":"18419","DOI":"10.1021\/jacs.2c06877","article-title":"Engineering poly(ethylene glycol) nanoparticles for accelerated blood clearance inhibition and targeted drug delivery","volume":"144","author":"Tian","year":"2022","journal-title":"J. Am. Chem. Soc."},{"issue":"26","key":"10.1016\/j.mtbio.2026.103568_bib50","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202405444","article-title":"One-component cationic lipids for systemic mRNA delivery to splenic T cells","volume":"63","author":"Zhang","year":"2024","journal-title":"Angew Chem. Int. Ed. Engl."},{"issue":"8","key":"10.1016\/j.mtbio.2026.103568_bib51","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202512535","article-title":"A rationally engineered spleen-tropic one-component Lipid-mRNA complex (OncoLRC) for cancer vaccines","volume":"13","author":"Yin","year":"2026","journal-title":"Adv. Sci."},{"issue":"11","key":"10.1016\/j.mtbio.2026.103568_bib52","doi-asserted-by":"crossref","first-page":"4029","DOI":"10.1021\/acs.molpharmaceut.1c00461","article-title":"Single micelle vectors based on lipid\/block copolymer compositions as mRNA formulations for efficient cancer immunogene therapy","volume":"18","author":"Li","year":"2021","journal-title":"Mol. Pharm."},{"issue":"1","key":"10.1016\/j.mtbio.2026.103568_bib53","doi-asserted-by":"crossref","first-page":"5659","DOI":"10.1038\/s41467-024-50093-7","article-title":"Reformulating lipid nanoparticles for organ-targeted mRNA accumulation and translation","volume":"15","author":"Su","year":"2024","journal-title":"Nat. Commun."},{"issue":"17","key":"10.1016\/j.mtbio.2026.103568_bib54","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202500306","article-title":"A versatile strategy to transform cationic polymers for efficient and organ-selective mRNA delivery","volume":"64","author":"Lin","year":"2025","journal-title":"Angew. Chem. Int. Ed."},{"issue":"42","key":"10.1016\/j.mtbio.2026.103568_bib55","doi-asserted-by":"crossref","first-page":"38865","DOI":"10.1021\/jacs.5c14870","article-title":"Computationally aided design of ionizable cholesteryl lipids for lipid nanoparticles to modulate hepatic mRNA accumulation","volume":"147","author":"Teng","year":"2025","journal-title":"J. Am. Chem. Soc."},{"issue":"25","key":"10.1016\/j.mtbio.2026.103568_bib56","doi-asserted-by":"crossref","first-page":"36377","DOI":"10.1021\/acsami.5c04597","article-title":"Ionizable sterol lipid-based three-component lipid nanoparticles for localized delivery of mRNA vaccine with stronger cellular immune responses","volume":"17","author":"Wang","year":"2025","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"35","key":"10.1016\/j.mtbio.2026.103568_bib57","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202313791","article-title":"Expanding RNAi to kidneys, lungs, and spleen via selective ORgan targeting (SORT) siRNA lipid nanoparticles","volume":"36","author":"Vaidya","year":"2024","journal-title":"Adv. Mater."},{"issue":"3","key":"10.1016\/j.mtbio.2026.103568_bib58","doi-asserted-by":"crossref","first-page":"4416","DOI":"10.1021\/acsami.4c14203","article-title":"Ionizable cholesterol analogs as the fifth component of lipid nanoparticles for selective targeting delivery of mRNA","volume":"17","author":"Liu","year":"2025","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"28","key":"10.1016\/j.mtbio.2026.103568_bib59","doi-asserted-by":"crossref","first-page":"6527","DOI":"10.1039\/D3TB00649B","article-title":"Rational design and combinatorial chemistry of ionizable lipids for RNA delivery","volume":"11","author":"Xu","year":"2023","journal-title":"J. Mater. Chem. B"},{"issue":"15","key":"10.1016\/j.mtbio.2026.103568_bib60","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202501037","article-title":"Rational design of unsaturated, thioether ionizable lipids for enhanced in vivo mRNA delivery","volume":"14","author":"Samaridou","year":"2025","journal-title":"Adv. Healthcare Mater."},{"issue":"6","key":"10.1016\/j.mtbio.2026.103568_bib63","doi-asserted-by":"crossref","DOI":"10.1002\/btm2.10556","article-title":"Novel piperazine-based ionizable lipid nanoparticles allow the repeated dose of mRNA to fibrotic lungs with improved potency and safety","volume":"8","author":"Kim","year":"2023","journal-title":"Bioeng. Transl. Med."},{"issue":"8","key":"10.1016\/j.mtbio.2026.103568_bib69","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2116271119","article-title":"Lung-selective mRNA delivery of synthetic lipid nanoparticles for the treatment of pulmonary lymphangioleiomyomatosis","volume":"119","author":"Qiu","year":"2022","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"10","key":"10.1016\/j.mtbio.2026.103568_bib70","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2020401118","article-title":"Lipid nanoparticle-mediated codelivery of Cas9 mRNA and single-guide RNA achieves liver-specific in vivo genome editing of Angptl3","volume":"118","author":"Qiu","year":"2021","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"22","key":"10.1016\/j.mtbio.2026.103568_bib61","doi-asserted-by":"crossref","first-page":"15085","DOI":"10.1021\/jacs.4c00451","article-title":"Multicomponent synthesis of imidazole-based ionizable lipids for highly efficient and spleen-selective messenger RNA delivery","volume":"146","author":"Dong","year":"2024","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.mtbio.2026.103568_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2022.121645","article-title":"An optimized ionizable cationic lipid for brain tumor-targeted siRNA delivery and glioblastoma immunotherapy","volume":"287","author":"Liu","year":"2022","journal-title":"Biomaterials"},{"issue":"5","key":"10.1016\/j.mtbio.2026.103568_bib64","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2409572122","article-title":"Rational design and modular synthesis of biodegradable ionizable lipids via the passerini reaction for mRNA delivery","volume":"122","author":"Xu","year":"2025","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"6","key":"10.1016\/j.mtbio.2026.103568_bib65","doi-asserted-by":"crossref","first-page":"6571","DOI":"10.1021\/acsnano.4c18636","article-title":"Ionizable lipids with optimized linkers enable lung-specific, lipid nanoparticle-mediated mRNA delivery for treatment of metastatic lung tumors","volume":"19","author":"Somu Naidu","year":"2025","journal-title":"ACS Nano"},{"key":"10.1016\/j.mtbio.2026.103568_bib66","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.124868","article-title":"Multiple tail ionizable lipids improve in vivo mRNA delivery efficiency with biosafety","volume":"667","author":"Liu","year":"2024","journal-title":"Int. J. Pharm."},{"issue":"2","key":"10.1016\/j.mtbio.2026.103568_bib67","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.jconrel.2005.06.014","article-title":"Cationic lipid saturation influences intracellular delivery of encapsulated nucleic acids","volume":"107","author":"Heyes","year":"2005","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.mtbio.2026.103568_bib68","doi-asserted-by":"crossref","DOI":"10.1016\/j.mattod.2026.103373","article-title":"Lipid tail heterogeneity enables organ-selective mRNA delivery for in vivo CRISPR-Cas9 gene editing","volume":"97","author":"Liao","year":"2026","journal-title":"Mater. Today"},{"issue":"41","key":"10.1016\/j.mtbio.2026.103568_bib71","first-page":"12758","article-title":"Impact of lipid tail length on the organ selectivity of mRNA-Lipid nanoparticles","volume":"24","author":"Hashiba","year":"2024","journal-title":"Nano Lett."},{"issue":"2","key":"10.1016\/j.mtbio.2026.103568_bib72","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1021\/jacs.4c10265","article-title":"Multiarm-assisted design of dendron-like degradable ionizable lipids facilitates systemic mRNA delivery to the spleen","volume":"147","author":"Xue","year":"2025","journal-title":"J. Am. Chem. Soc."},{"issue":"1","key":"10.1016\/j.mtbio.2026.103568_bib73","doi-asserted-by":"crossref","first-page":"6305","DOI":"10.1038\/s41467-024-50619-z","article-title":"AGILE platform: a deep learning powered approach to accelerate LNP development for mRNA delivery","volume":"15","author":"Xu","year":"2024","journal-title":"Nat. Commun."},{"issue":"6","key":"10.1016\/j.mtbio.2026.103568_bib74","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1016\/j.cell.2026.01.012","article-title":"LUMI-lab: a foundation model-driven autonomous platform enabling discovery of ionizable lipid designs for mRNA delivery","volume":"189","author":"Xu","year":"2026","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.mtbio.2026.103568_bib75","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7150\/thno.89913","article-title":"Bile acid-containing lipid nanoparticles enhance extrahepatic mRNA delivery","volume":"14","author":"Patel","year":"2024","journal-title":"Theranostics"},{"key":"10.1016\/j.mtbio.2026.103568_bib76","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202503034","article-title":"Endogenous corticosteroid derived lipid nanoparticles (cortico LNPs) enable selective mRNA delivery to the spleen","author":"Isaac","year":"2025","journal-title":"Small"},{"issue":"4","key":"10.1016\/j.mtbio.2026.103568_bib79","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1039\/D0BM01609H","article-title":"Helper lipid structure influences protein adsorption and delivery of lipid nanoparticles to spleen and liver","volume":"9","author":"Zhang","year":"2021","journal-title":"Biomater. Sci."},{"issue":"1","key":"10.1016\/j.mtbio.2026.103568_bib81","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/s41467-025-67331-1","article-title":"mRNA vaccine developed for sequential selective organ-to-cell targeting of glioma","volume":"17","author":"Shi","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.mtbio.2026.103568_bib77","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2025.107182","article-title":"The impact of lipid compositions on siRNA and mRNA lipid nanoparticle performance for pulmonary delivery","volume":"212","author":"Rademacker","year":"2025","journal-title":"Eur. J. Pharmaceut. Sci."},{"key":"10.1016\/j.mtbio.2026.103568_bib78","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2025.123671","article-title":"Investigating the functional contributions of phospholipids in selective organ targeting lipid nanoparticles","volume":"326","author":"Guerrero","year":"2026","journal-title":"Biomaterials"},{"issue":"10","key":"10.1016\/j.mtbio.2026.103568_bib80","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202500878","article-title":"Ultrasound-enhanced spleen-targeted mRNA delivery via fluorinated PEGylated lipid nanoparticles for immunotherapy","volume":"64","author":"Chen","year":"2025","journal-title":"Angew Chem. Int. Ed. Engl."},{"issue":"4","key":"10.1016\/j.mtbio.2026.103568_bib82","doi-asserted-by":"crossref","DOI":"10.1016\/j.cclet.2023.108619","article-title":"Formation mechanism for stable system of nanoparticle\/protein Corona and phospholipid membrane","volume":"35","author":"Zhang","year":"2024","journal-title":"Chin. Chem. Lett."},{"issue":"12","key":"10.1016\/j.mtbio.2026.103568_bib83","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1038\/nnano.2012.207","article-title":"Biomolecular coronas provide the biological identity of nanosized materials","volume":"7","author":"Monopoli","year":"2012","journal-title":"Nat. Nanotechnol."},{"issue":"5","key":"10.1016\/j.mtbio.2026.103568_bib84","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1039\/D5PM00079C","article-title":"A new strategy for the extrahepatic delivery of lipid-based nanomedicines: a protein corona-mediated selective targeting system based on an ionizable cationic lipid library","volume":"2","author":"Younis","year":"2025","journal-title":"RSC Pharmaceutics"},{"key":"10.1016\/j.mtbio.2026.103568_bib85","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jconrel.2024.02.020","article-title":"Lipid-mediated protein corona regulation with increased apolipoprotein A-I recruitment for glioma targeting","volume":"368","author":"Zhang","year":"2024","journal-title":"J. Contr. Release"},{"issue":"1","key":"10.1016\/j.mtbio.2026.103568_bib86","doi-asserted-by":"crossref","first-page":"7926","DOI":"10.1038\/s41467-025-63198-4","article-title":"Galloylated liposomes enable targeted drug delivery by overcoming protein corona shielding","volume":"16","author":"Li","year":"2025","journal-title":"Nat. Commun."},{"issue":"7","key":"10.1016\/j.mtbio.2026.103568_bib87","doi-asserted-by":"crossref","first-page":"3195","DOI":"10.1016\/j.ymthe.2025.03.018","article-title":"CD47 peptide-cloaked lipid nanoparticles promote cell-specific mRNA delivery","volume":"33","author":"Papp","year":"2025","journal-title":"Mol. Ther."},{"issue":"7","key":"10.1016\/j.mtbio.2026.103568_bib88","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1073\/pnas.0608582104","article-title":"Understanding the nanoparticle-protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles","volume":"104","author":"Cedervall","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.mtbio.2026.103568_bib89","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.actbio.2021.07.074","article-title":"Spotlight on the protein corona of liposomes","volume":"134","author":"Onishchenko","year":"2021","journal-title":"Acta Biomater."},{"issue":"10","key":"10.1016\/j.mtbio.2026.103568_bib90","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1038\/nnano.2013.181","article-title":"Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology","volume":"8","author":"Tenzer","year":"2013","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.mtbio.2026.103568_bib91","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.jconrel.2024.07.044","article-title":"Biofluid specific protein coronas affect lipid nanoparticle behavior in vitro","volume":"373","author":"van Straten","year":"2024","journal-title":"J. Contr. Release"},{"issue":"21","key":"10.1016\/j.mtbio.2026.103568_bib92","doi-asserted-by":"crossref","first-page":"7579","DOI":"10.1039\/D2CS00998F","article-title":"\u2018Passive\u2019 nanoparticles for organ-selective systemic delivery: design, mechanism and perspective","volume":"52","author":"Fu","year":"2023","journal-title":"Chem. Soc. Rev."},{"issue":"21","key":"10.1016\/j.mtbio.2026.103568_bib93","doi-asserted-by":"crossref","first-page":"12992","DOI":"10.1021\/acs.jmedchem.0c01407","article-title":"Property-driven design and development of lipids for efficient delivery of siRNA","volume":"63","author":"Rajappan","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.mtbio.2026.103568_bib94","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.jconrel.2023.07.058","article-title":"The interplay of Quaternary ammonium lipid structure and protein corona on lung-specific mRNA delivery by selective organ targeting (SORT) nanoparticles","volume":"361","author":"Dilliard","year":"2023","journal-title":"J. Contr. Release"},{"issue":"40","key":"10.1016\/j.mtbio.2026.103568_bib107","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202507657","article-title":"Reengineering endogenous targeting lipid nanoparticles (ENDO) for systemic delivery of mRNA to pancreas","volume":"37","author":"Isaac","year":"2025","journal-title":"Adv. Mater."},{"issue":"12","key":"10.1016\/j.mtbio.2026.103568_bib95","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1038\/s41565-019-0591-y","article-title":"The onpattro story and the clinical translation of nanomedicines containing nucleic acid-based drugs","volume":"14","author":"Akinc","year":"2019","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.mtbio.2026.103568_bib96","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/978-1-0716-2879-9_12","article-title":"The delivery of ABE mRNA to the adult murine liver by lipid nanoparticles (LNPs)","volume":"2606","author":"Yang","year":"2023","journal-title":"Methods Mol. Biol."},{"issue":"4","key":"10.1016\/j.mtbio.2026.103568_bib97","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/s41565-020-0669-6","article-title":"Selective organ targeting (SORT) nanoparticles for tissue-specific mRNA delivery and CRISPR-cas gene editing","volume":"15","author":"Cheng","year":"2020","journal-title":"Nat. Nanotechnol."},{"issue":"4","key":"10.1016\/j.mtbio.2026.103568_bib98","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1021\/acs.biomac.5b00108","article-title":"Protein Corona of nanoparticles: distinct proteins regulate the cellular uptake","volume":"16","author":"Ritz","year":"2015","journal-title":"Biomacromolecules"},{"issue":"2","key":"10.1016\/j.mtbio.2026.103568_bib99","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/j.apsb.2025.01.015","article-title":"Enhanced BBB penetration and microglia-targeting nanomodulator for the two-pronged modulation of chronically activated microglia-mediated neuroinflammation in Alzheimer's disease","volume":"15","author":"Wei","year":"2025","journal-title":"Acta Pharm. Sin. B"},{"issue":"3","key":"10.1016\/j.mtbio.2026.103568_bib100","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1002\/hep.510270328","article-title":"Expression of integrins during liver organogenesis in humans","volume":"27","author":"Couvelard","year":"1998","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.mtbio.2026.103568_bib101","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/s12967-018-1474-y","article-title":"The positive role of vitronectin in radiation induced lung toxicity: the in vitro and in vivo mechanism study","volume":"16","author":"Shen","year":"2018","journal-title":"J. Transl. Med."},{"issue":"2","key":"10.1016\/j.mtbio.2026.103568_bib102","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.113799","article-title":"Macrophage-induced integrin signaling promotes Schlemm's canal formation to prevent intraocular hypertension and glaucomatous optic neuropathy","volume":"43","author":"Gu","year":"2024","journal-title":"Cell Rep."},{"issue":"2","key":"10.1016\/j.mtbio.2026.103568_bib103","first-page":"204","article-title":"Phosphatidylserine exposure on stored red blood cells as a parameter for donor-dependent variation in product quality","volume":"12","author":"Dinkla","year":"2014","journal-title":"Blood Transfus"},{"issue":"3","key":"10.1016\/j.mtbio.2026.103568_bib104","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.4049\/jimmunol.174.3.1393","article-title":"Interaction between phosphatidylserine and the phosphatidylserine receptor inhibits immune responses in vivo","volume":"174","author":"Hoffmann","year":"2005","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.mtbio.2026.103568_bib105","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s10495-005-0817-3","article-title":"Recruitment of beta-2-glycoprotein 1 to cell surfaces in extrinsic and intrinsic apoptosis","volume":"10","author":"Balasubramanian","year":"2005","journal-title":"Apoptosis"},{"issue":"34","key":"10.1016\/j.mtbio.2026.103568_bib106","doi-asserted-by":"crossref","first-page":"30860","DOI":"10.1021\/acsnano.5c05370","article-title":"Endogenous targeting of lipid nanoparticles to kidney tumors","volume":"19","author":"Vaidya","year":"2025","journal-title":"ACS Nano"},{"issue":"5","key":"10.1016\/j.mtbio.2026.103568_bib108","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1080\/01635581.2018.1521445","article-title":"Modulation of VDR and cell cycle-related proteins by vitamin D in normal pancreatic cells and poorly differentiated metastatic pancreatic cancer cells","volume":"71","author":"Li","year":"2019","journal-title":"Nutr. Cancer"},{"issue":"7","key":"10.1016\/j.mtbio.2026.103568_bib109","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.1007\/s10620-023-07931-3","article-title":"Activation of vitamin D\/VDR signaling reverses gemcitabine resistance of pancreatic cancer cells through inhibition of MUC1 expression","volume":"68","author":"Wei","year":"2023","journal-title":"Dig. Dis. Sci."},{"issue":"1","key":"10.1016\/j.mtbio.2026.103568_bib110","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1021\/acs.jmedchem.0c01197","article-title":"Novel nonsecosteroidal vitamin D receptor modulator combined with gemcitabine enhances pancreatic cancer therapy through remodeling of the tumor microenvironment","volume":"64","author":"Kang","year":"2021","journal-title":"J. Med. Chem."},{"issue":"6","key":"10.1016\/j.mtbio.2026.103568_bib111","doi-asserted-by":"crossref","first-page":"2818","DOI":"10.1016\/j.apsb.2025.05.007","article-title":"Advancements in CRISPR\/cas systems for disease treatment","volume":"15","author":"Xu","year":"2025","journal-title":"Acta Pharm. Sin. B"},{"issue":"1","key":"10.1016\/j.mtbio.2026.103568_bib112","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/s41565-024-01747-6","article-title":"Combinatorial design of siloxane-incorporated lipid nanoparticles augments intracellular processing for tissue-specific mRNA therapeutic delivery","volume":"20","author":"Xue","year":"2025","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.mtbio.2026.103568_bib113","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1038\/s41563-025-02284-w","article-title":"Albumin-recruiting lipid nanoparticle potentiates the safety and efficacy of mRNA vaccines by avoiding liver accumulation","volume":"24","author":"Feng","year":"2025","journal-title":"Nat. Mater."},{"issue":"12","key":"10.1016\/j.mtbio.2026.103568_bib114","doi-asserted-by":"crossref","first-page":"7347","DOI":"10.1021\/acs.molpharmaceut.5c00348","article-title":"Structure-based modeling of environment-dependent protonation states across LNP formulations with atomistic CpHMD","volume":"22","author":"Colston","year":"2025","journal-title":"Mol. Pharm."},{"issue":"34","key":"10.1016\/j.mtbio.2026.103568_bib115","doi-asserted-by":"crossref","first-page":"8657","DOI":"10.1002\/ange.201203263","article-title":"Maximizing the potency of siRNA lipid nanoparticles for hepatic gene silencing in vivo","volume":"124","author":"Jayaraman","year":"2012","journal-title":"Angew. Chem."},{"issue":"52","key":"10.1016\/j.mtbio.2026.103568_bib116","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2109256118","article-title":"On the mechanism of tissue-specific mRNA delivery by selective organ targeting nanoparticles","volume":"118","author":"Dilliard","year":"2021","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"3","key":"10.1016\/j.mtbio.2026.103568_bib117","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202407040","article-title":"Zwitterionic polymer lipid nanoparticles enabling selective organ targeting delivery of small interfering RNA for the treatment of hepatic and pulmonary inflammation","volume":"21","author":"Li","year":"2025","journal-title":"Small"},{"key":"10.1016\/j.mtbio.2026.103568_bib120","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jconrel.2021.05.021","article-title":"Impact of lipid nanoparticle size on mRNA vaccine immunogenicity","volume":"335","author":"Hassett","year":"2021","journal-title":"J. Contr. Release"},{"issue":"22","key":"10.1016\/j.mtbio.2026.103568_bib125","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202400225","article-title":"Branched-tail lipid nanoparticles for intravenous mRNA delivery to lung immune, endothelial, and alveolar cells in mice","volume":"13","author":"Petersen","year":"2024","journal-title":"Adv. Healthcare Mater."},{"issue":"9","key":"10.1016\/j.mtbio.2026.103568_bib118","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202105832","article-title":"Mechanistic studies of an automated lipid nanoparticle reveal critical pharmaceutical properties associated with enhanced mRNA functional delivery in vitro and in vivo","volume":"18","author":"Cui","year":"2022","journal-title":"Small"},{"key":"10.1016\/j.mtbio.2026.103568_bib119","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.jconrel.2024.07.059","article-title":"Effects of phospholipid type and particle size on lipid nanoparticle distribution in vivo and in pancreatic islets","volume":"373","author":"Oguma","year":"2024","journal-title":"J. Contr. Release"},{"issue":"4","key":"10.1016\/j.mtbio.2026.103568_bib121","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics17040459","article-title":"Predictive Lung- and spleen-targeted mRNA delivery with biodegradable ionizable lipids in four-component LNPs","volume":"17","author":"Heredero","year":"2025","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/j.mtbio.2026.103568_bib122","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/s41596-022-00755-x","article-title":"Preparation of selective organ-targeting (SORT) lipid nanoparticles (LNPs) using multiple technical methods for tissue-specific mRNA delivery","volume":"18","author":"Wang","year":"2023","journal-title":"Nat. Protoc."},{"issue":"21","key":"10.1016\/j.mtbio.2026.103568_bib123","doi-asserted-by":"crossref","first-page":"30625","DOI":"10.1021\/acsami.5c03743","article-title":"Exaggerated lung inflammation induced by lung-targeted mRNA-LNP dampens vaccines against tuberculosis","volume":"17","author":"Li","year":"2025","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"20","key":"10.1016\/j.mtbio.2026.103568_bib124","doi-asserted-by":"crossref","first-page":"25698","DOI":"10.1021\/acsami.4c02415","article-title":"Cationic lipid pairs enhance liver-to-lung tropism of lipid nanoparticles for in vivo mRNA delivery","volume":"16","author":"Zeng","year":"2024","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"9","key":"10.1016\/j.mtbio.2026.103568_bib126","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1038\/s41551-021-00786-x","article-title":"Optimization of lipid nanoparticles for the delivery of nebulized therapeutic mRNA to the lungs","volume":"5","author":"Lokugamage","year":"2021","journal-title":"Nat. Biomed. Eng."},{"issue":"10","key":"10.1016\/j.mtbio.2026.103568_bib127","doi-asserted-by":"crossref","first-page":"7079","DOI":"10.4049\/jimmunol.179.10.7079","article-title":"Involvement of vitronectin in lipopolysaccaride-induced acute lung injury","volume":"179","author":"Tsuruta","year":"2007","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.mtbio.2026.103568_bib128","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/s41565-020-0669-6","article-title":"Selective organ targeting (SORT) nanoparticles for tissue-specific mRNA delivery and CRISPR\u2013cas gene editing","volume":"15","author":"Cheng","year":"2020","journal-title":"Nat. Nanotechnol."},{"issue":"9","key":"10.1016\/j.mtbio.2026.103568_bib129","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abf4398","article-title":"Engineered ionizable lipid nanoparticles for targeted delivery of RNA therapeutics into different types of cells in the liver","volume":"7","author":"Kim","year":"2021","journal-title":"Sci. Adv."},{"issue":"10","key":"10.1016\/j.mtbio.2026.103568_bib130","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1021\/acs.bioconjchem.5c00282","article-title":"Mannose-conjugated cholesterol containing lipid nanoparticles for active targeted mRNA delivery to liver sinusoidal endothelial and kupffer cells","volume":"36","author":"Kim","year":"2025","journal-title":"Bioconjug. Chem."},{"issue":"Pt 3","key":"10.1016\/j.mtbio.2026.103568_bib131","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1242\/jcs.108.3.1227","article-title":"Alpha v beta 1 is a receptor for vitronectin and fibrinogen, and acts with alpha 5 beta 1 to mediate spreading on fibronectin","volume":"108","author":"Marshall","year":"1995","journal-title":"J. Cell Sci."},{"issue":"1","key":"10.1016\/j.mtbio.2026.103568_bib132","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/s41563-025-02320-9","article-title":"Tissue-specific mRNA delivery and prime editing with peptide\u2013ionizable lipid nanoparticles","volume":"25","author":"Lin","year":"2026","journal-title":"Nat. Mater."},{"key":"10.1016\/j.mtbio.2026.103568_bib133","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.addr.2020.06.017","article-title":"Lipid-based nanoparticle technologies for liver targeting","volume":"154-155","author":"B\u00f6ttger","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"1","key":"10.1016\/j.mtbio.2026.103568_bib134","doi-asserted-by":"crossref","first-page":"4135","DOI":"10.1038\/s41467-025-58523-w","article-title":"Liposomal lipid nanoparticles for extrahepatic delivery of mRNA","volume":"16","author":"Cheng","year":"2025","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.mtbio.2026.103568_bib135","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/imr.12337","article-title":"The era of the immunoglobulin A Fc receptor Fc\u03b1RI; its function and potential as target in disease","volume":"268","author":"Aleyd","year":"2015","journal-title":"Immunol. Rev."},{"issue":"2","key":"10.1016\/j.mtbio.2026.103568_bib136","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/nri3582","article-title":"The function of Fc\u03b3 receptors in dendritic cells and macrophages","volume":"14","author":"Guilliams","year":"2014","journal-title":"Nat. Rev. Immunol."},{"issue":"2","key":"10.1016\/j.mtbio.2026.103568_bib137","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0005-2736(01)00330-3","article-title":"Protein adsorption to polyethylene glycol modified liposomes from fibrinogen solution and from plasma","volume":"1512","author":"Price","year":"2001","journal-title":"Biochim. Biophys. Acta"},{"issue":"1\u20132","key":"10.1016\/j.mtbio.2026.103568_bib138","first-page":"176","article-title":"Inherited fibrinogen abnormality causing thrombophilia","volume":"17","author":"Egeberg","year":"1967","journal-title":"Thrombosis Diath. Haemorrh."},{"issue":"12","key":"10.1016\/j.mtbio.2026.103568_bib139","doi-asserted-by":"crossref","first-page":"4822","DOI":"10.1021\/acs.nanolett.2c01133","article-title":"Universal barcoding predicts in vivo ApoE-Independent lipid nanoparticle delivery","volume":"22","author":"Da Silva Sanchez","year":"2022","journal-title":"Nano Lett."},{"key":"10.1016\/j.mtbio.2026.103568_bib140","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jconrel.2022.11.036","article-title":"siRNA delivery to lymphatic endothelial cells via ApoE-mediated uptake by lipid nanoparticles","volume":"353","author":"Sakurai","year":"2023","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.mtbio.2026.103568_bib141","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.jconrel.2020.02.040","article-title":"Targeting cancer-associated fibroblasts by dual-responsive lipid-albumin nanoparticles to enhance drug perfusion for pancreatic tumor therapy","volume":"321","author":"Yu","year":"2020","journal-title":"J. Contr. Release"},{"issue":"1","key":"10.1016\/j.mtbio.2026.103568_bib142","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1038\/s41467-025-56448-y","article-title":"Targeted delivery of TGF-\u03b2 mRNA to murine lung parenchyma using one-component ionizable amphiphilic janus dendrimers","volume":"16","author":"Meshanni","year":"2025","journal-title":"Nat. Commun."},{"issue":"14","key":"10.1016\/j.mtbio.2026.103568_bib143","article-title":"Lung-specific mRNA delivery by ionizable lipids with defined structure-function relationship and unique protein Corona feature","volume":"12","author":"He","year":"2025","journal-title":"Adv. Sci. (Weinh.)"},{"issue":"26","key":"10.1016\/j.mtbio.2026.103568_bib144","doi-asserted-by":"crossref","first-page":"8080","DOI":"10.1021\/acs.nanolett.4c01854","article-title":"Lung-specific mRNA delivery enabled by sulfonium lipid nanoparticles","volume":"24","author":"Popoola","year":"2024","journal-title":"Nano Lett."},{"issue":"22","key":"10.1016\/j.mtbio.2026.103568_bib145","doi-asserted-by":"crossref","first-page":"15085","DOI":"10.1021\/jacs.4c00451","article-title":"Multicomponent synthesis of imidazole-based ionizable lipids for highly efficient and spleen-selective messenger RNA delivery","volume":"146","author":"Dong","year":"2024","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.mtbio.2026.103568_bib146","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.jconrel.2020.01.024","article-title":"Co-delivery of p38\u03b1 MAPK and p65 siRNA by novel liposomal glomerulus-targeting nano carriers for effective immunoglobulin a nephropathy treatment","volume":"320","author":"Wang","year":"2020","journal-title":"J. Contr. Release"},{"issue":"9","key":"10.1016\/j.mtbio.2026.103568_bib147","doi-asserted-by":"crossref","first-page":"5533","DOI":"10.1021\/acs.molpharmaceut.5c00559","article-title":"Lipid-modified bilirubin nanocrystals for the repair of ischemia-reperfusion-induced acute kidney injury","volume":"22","author":"Yuan","year":"2025","journal-title":"Mol. Pharm."},{"issue":"1","key":"10.1016\/j.mtbio.2026.103568_bib148","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1038\/s41467-025-57488-0","article-title":"Berberine-inspired ionizable lipid for self-structure stabilization and brain targeting delivery of nucleic acid therapeutics","volume":"16","author":"Bian","year":"2025","journal-title":"Nat. Commun."},{"issue":"19","key":"10.1016\/j.mtbio.2026.103568_bib149","doi-asserted-by":"crossref","first-page":"16007","DOI":"10.1021\/jacs.4c16326","article-title":"Furan-derived lipid nanoparticles for transporting mRNA to the central nervous system","volume":"147","author":"Liu","year":"2025","journal-title":"J. Am. Chem. Soc."},{"issue":"2","key":"10.1016\/j.mtbio.2026.103568_bib150","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1021\/acs.nanolett.4c05186","article-title":"Peptide-functionalized lipid nanoparticles for targeted systemic mRNA delivery to the brain","volume":"25","author":"Han","year":"2025","journal-title":"Nano Lett."},{"key":"10.1016\/j.mtbio.2026.103568_bib151","doi-asserted-by":"crossref","DOI":"10.1016\/j.matdes.2025.114288","article-title":"Biomimetic siRNA-METTL3 loading nanosystem alleviates myocardial hypertrophy by regulating the FASN and SCD1 m6A modification","volume":"256","author":"Teng","year":"2025","journal-title":"Mater. Des."},{"key":"10.1016\/j.mtbio.2026.103568_bib152","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.113623","article-title":"Effective transcatheter intracoronary delivery of mRNA-lipid nanoparticles targeting the heart","volume":"381","author":"Handa","year":"2025","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.mtbio.2026.103568_bib153","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jconrel.2023.06.014","article-title":"The role of protein corona on nanodrugs for organ-targeting and its prospects of application","volume":"360","author":"Wang","year":"2023","journal-title":"J. Contr. Release"},{"issue":"26","key":"10.1016\/j.mtbio.2026.103568_bib154","doi-asserted-by":"crossref","first-page":"27898","DOI":"10.1021\/acsomega.3c08288","article-title":"Preadsorbed chymotrypsin modulated the composition of protein Corona and immunological response","volume":"9","author":"Han","year":"2024","journal-title":"ACS Omega"},{"issue":"24","key":"10.1016\/j.mtbio.2026.103568_bib155","doi-asserted-by":"crossref","first-page":"13171","DOI":"10.1021\/am404171h","article-title":"Selective targeting capability acquired with a protein corona adsorbed on the surface of 1,2-dioleoyl-3-trimethylammonium propane\/DNA nanoparticles","volume":"5","author":"Caracciolo","year":"2013","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"7","key":"10.1016\/j.mtbio.2026.103568_bib156","doi-asserted-by":"crossref","DOI":"10.3390\/cells10071684","article-title":"Nano-strategies targeting the integrin \u03b1v\u03b23 network for cancer therapy","volume":"10","author":"Cheng","year":"2021","journal-title":"Cells"},{"issue":"2","key":"10.1016\/j.mtbio.2026.103568_bib157","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1080\/10623320600698037","article-title":"Vascular integrins in tumor angiogenesis: mediators and therapeutic targets","volume":"13","author":"Alghisi","year":"2006","journal-title":"Endothelium"},{"issue":"10","key":"10.1016\/j.mtbio.2026.103568_bib158","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1021\/acs.bioconjchem.3c00329","article-title":"Protein Corona formation on lipid nanoparticles negatively affects the NLRP3 inflammasome activation","volume":"34","author":"Debnath","year":"2023","journal-title":"Bioconjug. Chem."},{"issue":"8","key":"10.1016\/j.mtbio.2026.103568_bib159","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1038\/s41418-022-00947-8","article-title":"Ubiquitination of NLRP3 by gp78\/Insig-1 restrains NLRP3 inflammasome activation","volume":"29","author":"Xu","year":"2022","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.mtbio.2026.103568_bib160","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.actbio.2025.07.068","article-title":"Inhalable nucleic acid therapeutics for chronic pulmonary disease: progress, challenges, and prospects","volume":"204","author":"Wang","year":"2025","journal-title":"Acta Biomater."},{"issue":"14","key":"10.1016\/j.mtbio.2026.103568_bib161","doi-asserted-by":"crossref","first-page":"13790","DOI":"10.1021\/acsnano.4c16617","article-title":"Lipid nanoparticles for in vivo lung delivery of CRISPR-Cas9 ribonucleoproteins allow gene editing of clinical targets","volume":"19","author":"Haley","year":"2025","journal-title":"ACS Nano"},{"key":"10.1016\/j.mtbio.2026.103568_bib162","doi-asserted-by":"crossref","first-page":"6853","DOI":"10.2147\/IJN.S521444","article-title":"Advancements in nanocarrier delivery systems for photodynamic therapy in lung cancer","volume":"20","author":"Wang","year":"2025","journal-title":"Int. J. Nanomed."},{"issue":"1","key":"10.1016\/j.mtbio.2026.103568_bib163","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1080\/10717544.2021.1931560","article-title":"A size-shrinkable matrix metallopeptidase-2-sensitive delivery nanosystem improves the penetration of human programmed death-ligand 1 siRNA into lung-tumor spheroids","volume":"28","author":"Wen","year":"2021","journal-title":"Drug Deliv."},{"issue":"732","key":"10.1016\/j.mtbio.2026.103568_bib164","doi-asserted-by":"crossref","first-page":"eadg6229","DOI":"10.1126\/scitranslmed.adg6229","article-title":"TGF-\u03b2R2 signaling coordinates pulmonary vascular repair after viral injury in mice and human tissue","volume":"16","author":"Zhao","year":"2024","journal-title":"Sci. Transl. Med."},{"issue":"10","key":"10.1016\/j.mtbio.2026.103568_bib165","doi-asserted-by":"crossref","first-page":"5416","DOI":"10.1016\/j.apsb.2025.07.004","article-title":"Targeted delivery of BMPR2 mRNA attenuates pulmonary arterial hypertension by reversing pulmonary vascular remodeling","volume":"15","author":"Cao","year":"2025","journal-title":"Acta Pharm. Sin. B"},{"issue":"1","key":"10.1016\/j.mtbio.2026.103568_bib166","doi-asserted-by":"crossref","first-page":"7322","DOI":"10.1038\/s41467-023-42948-2","article-title":"Lung SORT LNPs enable precise homology-directed repair mediated CRISPR\/cas genome correction in cystic fibrosis models","volume":"14","author":"Wei","year":"2023","journal-title":"Nat. Commun."},{"issue":"44","key":"10.1016\/j.mtbio.2026.103568_bib167","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202407398","article-title":"Development of organ targeting lipid nanoparticles with low immunogenicity and their application in the treatment of pulmonary fibrosis","volume":"63","author":"Cheng","year":"2024","journal-title":"Angew Chem. Int. Ed. Engl."},{"issue":"49","key":"10.1016\/j.mtbio.2026.103568_bib168","doi-asserted-by":"crossref","first-page":"34209","DOI":"10.1021\/jacs.4c14500","article-title":"Crown-like biodegradable lipids enable lung-selective mRNA delivery and dual-modal tumor imaging in vivo","volume":"146","author":"Chen","year":"2024","journal-title":"J. Am. Chem. Soc."},{"issue":"1","key":"10.1016\/j.mtbio.2026.103568_bib169","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1038\/s41467-024-45422-9","article-title":"High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","volume":"15","author":"Xue","year":"2024","journal-title":"Nat. Commun."},{"issue":"45","key":"10.1016\/j.mtbio.2026.103568_bib172","article-title":"Discovery of ketal-ester ionizable lipid nanoparticle with reduced hepatotoxicity, enhanced spleen tropism for mRNA vaccine delivery","volume":"11","author":"Lv","year":"2024","journal-title":"Adv. Sci. (Weinh.)"},{"issue":"3","key":"10.1016\/j.mtbio.2026.103568_bib198","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202415389","article-title":"Piperazine-derived bisphosphonate-based ionizable lipid nanoparticles enhance mRNA delivery to the bone microenvironment","volume":"64","author":"Yoon","year":"2025","journal-title":"Angew. Chem. Int. Ed."},{"issue":"41","key":"10.1016\/j.mtbio.2026.103568_bib170","doi-asserted-by":"crossref","first-page":"eady6460","DOI":"10.1126\/sciadv.ady6460","article-title":"Replacing cholesterol and PEGylated lipids with zwitterionic ionizable lipids in LNPs for spleen-specific mRNA translation","volume":"11","author":"Zhao","year":"2025","journal-title":"Sci. Adv."},{"issue":"3","key":"10.1016\/j.mtbio.2026.103568_bib171","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1007\/s12274-023-6111-2","article-title":"Natural long-chain saturated fatty acids doped LNPs enabling spleen selective mRNA translation and potent cancer immunotherapy","volume":"17","author":"Wang","year":"2024","journal-title":"Nano Res."},{"issue":"1","key":"10.1016\/j.mtbio.2026.103568_bib173","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.202420308","article-title":"PEG-free monosialoganglioside lipid nanoparticles with spleen-selective mRNA delivery for cancer immunotherapy","volume":"36","author":"Wang","year":"2026","journal-title":"Adv. Funct. Mater."},{"issue":"32","key":"10.1016\/j.mtbio.2026.103568_bib174","doi-asserted-by":"crossref","first-page":"28665","DOI":"10.1021\/jacs.5c01389","article-title":"Carbonate-bearing ionizable lipids for mRNA delivery to splenic NK cells","volume":"147","author":"Wu","year":"2025","journal-title":"J. Am. Chem. Soc."},{"issue":"30","key":"10.1016\/j.mtbio.2026.103568_bib175","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202520594","article-title":"A structurally stabilized lipopolymer nanoplatform targeting pan-tissue antigen-presenting cells enables durable in situ mRNA cancer immunotherapy","volume":"38","author":"Zeng","year":"2026","journal-title":"Adv. Mater."},{"issue":"34","key":"10.1016\/j.mtbio.2026.103568_bib176","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2207841119","article-title":"Lipid nanoparticle-mediated lymph node\u2013targeting delivery of mRNA cancer vaccine elicits robust CD8+ T cell response","volume":"119","author":"Chen","year":"2022","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"8","key":"10.1016\/j.mtbio.2026.103568_bib177","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1021\/acsptsci.5c00153","article-title":"Crossing barriers: advancements in macromolecular therapeutics for neurodegenerative diseases and strategies to overcome the blood\u2013brain barrier","volume":"8","author":"Alo","year":"2025","journal-title":"ACS Pharmacol. Transl. Sci."},{"issue":"1","key":"10.1016\/j.mtbio.2026.103568_bib178","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1186\/s12951-025-03415-w","article-title":"Advances in brain-targeted delivery strategies and natural product-mediated enhancement of blood\u2013brain barrier permeability","volume":"23","author":"Liu","year":"2025","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.mtbio.2026.103568_bib179","doi-asserted-by":"crossref","DOI":"10.1016\/j.cis.2023.103008","article-title":"Emerging strategies to fabricate polymeric nanocarriers for enhanced drug delivery across blood-brain barrier: an overview","volume":"320","author":"Song","year":"2023","journal-title":"Adv. Colloid Interface Sci."},{"issue":"41","key":"10.1016\/j.mtbio.2026.103568_bib180","doi-asserted-by":"crossref","first-page":"36106","DOI":"10.1021\/acsnano.4c15013","article-title":"AI-Validated brain targeted mRNA lipid nanoparticles with neuronal tropism","volume":"19","author":"Sela","year":"2025","journal-title":"ACS Nano"},{"key":"10.1016\/j.mtbio.2026.103568_bib181","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2023.114861","article-title":"Lipid nanoparticle-mediated drug delivery to the brain","volume":"197","author":"Khare","year":"2023","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"6","key":"10.1016\/j.mtbio.2026.103568_bib182","doi-asserted-by":"crossref","first-page":"2884","DOI":"10.1016\/j.apsb.2025.02.035","article-title":"Nose-to-brain delivery of targeted lipid nanoparticles as two-pronged \u03b2-amyloid nanoscavenger for Alzheimer's disease therapy","volume":"15","author":"Xu","year":"2025","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.mtbio.2026.103568_bib183","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2024.115219","article-title":"Interactions between nanoparticles and pathological changes of vascular in Alzheimer's disease","volume":"207","author":"Lei","year":"2024","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"4","key":"10.1016\/j.mtbio.2026.103568_bib184","doi-asserted-by":"crossref","DOI":"10.1016\/j.cclet.2024.109917","article-title":"Orally delivered berberine derivatives for dual therapy in diabetic complications with MRSA infections","volume":"36","author":"Gao","year":"2025","journal-title":"Chin. Chem. Lett."},{"issue":"8_Supplement_1","key":"10.1016\/j.mtbio.2026.103568_bib185","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1158\/1538-7445.AM2025-1854","article-title":"Abstract 1854: neurotransmitter-derived lipid nanoparticles (LNPs) for brain-targeted drug delivery","volume":"85","author":"Wang","year":"2025","journal-title":"Cancer Res."},{"issue":"33","key":"10.1016\/j.mtbio.2026.103568_bib186","doi-asserted-by":"crossref","first-page":"eadw0730","DOI":"10.1126\/sciadv.adw0730","article-title":"Lipid nanoparticles for mRNA delivery in brain via systemic administration","volume":"11","author":"Cao","year":"2025","journal-title":"Sci. Adv."},{"key":"10.1016\/j.mtbio.2026.103568_bib187","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.jconrel.2021.04.001","article-title":"Unmasking CSF protein corona: effect on targeting capacity of nanoparticles","volume":"333","author":"Wang","year":"2021","journal-title":"J. Contr. Release"},{"issue":"4","key":"10.1016\/j.mtbio.2026.103568_bib188","doi-asserted-by":"crossref","first-page":"3260","DOI":"10.1021\/acsnano.3c09817","article-title":"Targeted mRNA nanoparticles ameliorate blood-brain barrier disruption postischemic stroke by modulating microglia polarization","volume":"18","author":"Gao","year":"2024","journal-title":"ACS Nano"},{"issue":"2","key":"10.1016\/j.mtbio.2026.103568_bib189","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1152\/physiol.00018.2023","article-title":"From beats to metabolism: the heart at the core of interorgan metabolic cross talk","volume":"39","author":"Romero-Becera","year":"2024","journal-title":"Physiology"},{"key":"10.1016\/j.mtbio.2026.103568_bib190","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2025.123410","article-title":"LNPs-mediated VEGF-C mRNA delivery promotes heart repair and attenuates inflammation by stimulating lymphangiogenesis post-myocardial infarction","volume":"322","author":"Zhang","year":"2025","journal-title":"Biomaterials"},{"issue":"Supplement_2","key":"10.1016\/j.mtbio.2026.103568_bib191","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehad655.3301","article-title":"Effective cardiac mRNA delivery using lipid nanoparticles","volume":"44","author":"Labonia","year":"2023","journal-title":"Eur. Heart J."},{"issue":"29","key":"10.1016\/j.mtbio.2026.103568_bib192","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2409266122","article-title":"Systemic delivery of biotherapeutic RNA to the myocardium transiently modulates cardiac contractility in vivo","volume":"122","author":"Shuvaev","year":"2025","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"7","key":"10.1016\/j.mtbio.2026.103568_bib193","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1038\/s41551-025-01523-4","article-title":"A microphysiological system for screening lipid nanoparticle-mRNA complexes predicts in vivo heart transfection efficacy","volume":"10","author":"Neiman","year":"2026","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.mtbio.2026.103568_bib194","article-title":"Self-assembled extracellular matrix-lipid nanoparticle composite for site-specific siRNA delivery to improve cardiac repair post-myocardial infarction","volume":"34","author":"Wang","year":"2025","journal-title":"Mater. Today Bio"},{"key":"10.1016\/j.mtbio.2026.103568_bib195","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jconrel.2022.01.027","article-title":"Delivery of modified mRNA to damaged myocardium by systemic administration of lipid nanoparticles","volume":"343","author":"Evers","year":"2022","journal-title":"J. Contr. Release"},{"issue":"1","key":"10.1016\/j.mtbio.2026.103568_bib196","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/s41401-025-01628-1","article-title":"Sirtuin 6 mitigates thoracic aortic aneurysm progression via maintenance of mitochondria homeostasis in vascular smooth muscle cells","volume":"47","author":"Yu","year":"2026","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.mtbio.2026.103568_bib197","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2023.102067","article-title":"Alleviation of ischemia-reperfusion induced renal injury by chemically modified <em>SOD2<\/em> mRNA delivered via lipid nanoparticles","volume":"34","author":"Hou","year":"2023","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.mtbio.2026.103568_bib199","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2023.142841","article-title":"Cartilage-targeting mRNA-lipid nanoparticles rescue perifocal apoptotic chondrocytes for integrative cartilage repair","volume":"465","author":"Yu","year":"2023","journal-title":"Chem. Eng. J."},{"issue":"9","key":"10.1016\/j.mtbio.2026.103568_bib200","doi-asserted-by":"crossref","first-page":"3034","DOI":"10.1016\/j.ymthe.2022.06.012","article-title":"Lipid nanoparticle-mediated silencing of osteogenic suppressor GNAS leads to osteogenic differentiation of mesenchymal stem cells in vivo","volume":"30","author":"Basha","year":"2022","journal-title":"Mol. Ther."},{"issue":"19","key":"10.1016\/j.mtbio.2026.103568_bib204","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.1016\/j.vaccine.2022.03.030","article-title":"Benefit-risk assessment of COVID-19 vaccine, mRNA (comirnaty) for age 16\u201329 years","volume":"40","author":"Funk","year":"2022","journal-title":"Vaccine"},{"issue":"9","key":"10.1016\/j.mtbio.2026.103568_bib205","doi-asserted-by":"crossref","first-page":"971","DOI":"10.3390\/vaccines12090971","article-title":"Short-term active safety surveillance of the spikevax and nuvaxovid priming doses in Australia","volume":"12","author":"Reynolds","year":"2024","journal-title":"Vaccines"},{"issue":"1","key":"10.1016\/j.mtbio.2026.103568_bib206","doi-asserted-by":"crossref","first-page":"6118","DOI":"10.1038\/s41467-025-61153-x","article-title":"Immune correlates analysis of mRNA-1345 RSV vaccine efficacy clinical trial","volume":"16","author":"Ma","year":"2025","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.mtbio.2026.103568_bib207","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1080\/13696998.2025.2549630","article-title":"The potential impact of the next-generation COVID-19 mRNA-1283 vaccine in Canada","volume":"28","author":"Fust","year":"2025","journal-title":"J. Med. Econ."},{"key":"10.1016\/j.mtbio.2026.103568_bib208","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1016\/S0168-8278(22)00520-7","article-title":"OS073 - in vivo CRISPR\/Cas9 editing of the TTR gene with NTLA-2001 in patients with transthyretin amyloidosis- dose selection considerations","volume":"77","author":"Gane","year":"2022","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.mtbio.2026.103568_bib209","article-title":"Lessons from the first-in-human in vivo CRISPR\/Cas9 editing of the TTR gene by NTLA-2001 trial in patients with transthyretin amyloidosis with cardiomyopathy","volume":"2023","author":"Kotit","year":"2023","journal-title":"Glob Cardiol Sci Pract"},{"issue":"2","key":"10.1016\/j.mtbio.2026.103568_bib210","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1089\/nat.2022.0036","article-title":"Translational pharmacokinetic\/pharmacodynamic model for mRNA-3927, an investigational therapeutic for the treatment of propionic acidemia","volume":"33","author":"Attarwala","year":"2023","journal-title":"Nucleic Acid Therapeut."},{"key":"10.1016\/j.mtbio.2026.103568_bib211","doi-asserted-by":"crossref","DOI":"10.1016\/S1569-1993(21)01967-6","article-title":"544: safety and tolerability of single and repeat doses of MRT5005, an inhaled CFTR mRNA replacement therapy, in adult CF patients","volume":"20","author":"Rowe","year":"2021","journal-title":"J. Cyst. Fibros."},{"issue":"5","key":"10.1016\/j.mtbio.2026.103568_bib212","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/S1473-3099(22)00764-2","article-title":"The safety and immunogenicity of two zika virus mRNA vaccine candidates in healthy flavivirus baseline seropositive and seronegative adults: the results of two randomised, placebo-controlled, dose-ranging, phase 1 clinical trials","volume":"23","author":"Essink","year":"2023","journal-title":"Lancet Infect. Dis."},{"issue":"8","key":"10.1016\/j.mtbio.2026.103568_bib213","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/j.vaccine.2020.12.070","article-title":"Proof-of-concept of a low-dose unmodified mRNA-based rabies vaccine formulated with lipid nanoparticles in human volunteers: a phase 1 trial","volume":"39","author":"Aldrich","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.mtbio.2026.103568_bib214","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.jconrel.2024.11.023","article-title":"Preclinical development of lyophilized self-replicating RNA vaccines for COVID-19 and malaria with improved long-term thermostability","volume":"377","author":"Gulati","year":"2025","journal-title":"J. Contr. Release"},{"issue":"7\u20138","key":"10.1016\/j.mtbio.2026.103568_bib215","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1089\/hum.2025.040","article-title":"Beam results show first genetic correction of disease-causing mutation","volume":"36","author":"Philippidis","year":"2025","journal-title":"Hum. Gene Ther."},{"issue":"3","key":"10.1016\/j.mtbio.2026.103568_bib216","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1001\/jamaoncol.2024.5927","article-title":"Intratumoral injection of mRNA-2752 and pembrolizumab for high-risk ductal carcinoma in situ: a phase 1 nonrandomized clinical trial","volume":"11","author":"Ramalingam","year":"2025","journal-title":"JAMA Oncol."},{"issue":"11","key":"10.1016\/j.mtbio.2026.103568_bib217","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.3390\/vaccines9111345","article-title":"The importance of RNA-based vaccines in the fight against COVID-19: an overview","volume":"9","author":"Machado","year":"2021","journal-title":"Vaccines"},{"issue":"20","key":"10.1016\/j.mtbio.2026.103568_bib218","doi-asserted-by":"crossref","first-page":"3328","DOI":"10.3390\/cells11203328","article-title":"mRNA-Based approaches to treating liver diseases","volume":"11","author":"Cacicedo","year":"2022","journal-title":"Cells"},{"issue":"7","key":"10.1016\/j.mtbio.2026.103568_bib219","doi-asserted-by":"crossref","first-page":"730","DOI":"10.3390\/vaccines13070730","article-title":"Research progress on varicella-zoster virus vaccines","volume":"13","author":"Liu","year":"2025","journal-title":"Vaccines"},{"issue":"4","key":"10.1016\/j.mtbio.2026.103568_bib220","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1053\/j.ajkd.2019.09.011","article-title":"Chronic microangiopathy due to DCR-MYC, a myc-targeted short interfering RNA","volume":"75","author":"Miller","year":"2020","journal-title":"Am. J. Kidney Dis."},{"issue":"2","key":"10.1016\/j.mtbio.2026.103568_bib221","doi-asserted-by":"crossref","first-page":"AB147","DOI":"10.1016\/j.jaci.2020.12.531","article-title":"NTLA-2002: CRISPR\/Cas9-mediated gene knockout of KLKB1 to treat hereditary angioedema","volume":"147","author":"Seitzer","year":"2021","journal-title":"J. Allergy Clin. Immunol."},{"issue":"16_suppl","key":"10.1016\/j.mtbio.2026.103568_bib222","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1200\/JCO.2024.42.16_suppl.2539","article-title":"A phase I study to evaluate the safety and tolerability of JCXH-211 (a self-replicating mRNA encoding IL-12) intratumoral injection in patients with malignant solid tumors: results from the phase Ia dose escalation","volume":"42","author":"Le","year":"2024","journal-title":"J. Clin. Oncol."},{"issue":"9","key":"10.1016\/j.mtbio.2026.103568_bib223","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/s41422-025-01142-3","article-title":"Differentiation therapy with hepatocyte nuclear factor 4\u03b1 for patients with hepatocellular carcinoma","volume":"35","author":"Yin","year":"2025","journal-title":"Cell Res."},{"key":"10.1016\/j.mtbio.2026.103568_bib224","article-title":"283 safety and tolerability of inhaled LUNAR-CFTR mRNA (ARCT-032) demonstrated in a phase 1 study","volume":"23","author":"Geller","year":"2024","journal-title":"J. Cyst. Fibros."},{"issue":"8108","key":"10.1016\/j.mtbio.2026.103568_bib201","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1038\/s41586-026-10158-7","article-title":"Pancreatic-targeted lipid nanoparticles based on organ capsule filtration","volume":"652","author":"Lei","year":"2026","journal-title":"Nature"},{"key":"10.1016\/j.mtbio.2026.103568_bib202","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.113588","article-title":"Pancreas-targeted lipid nanoparticles for relatively non-invasive interleukin-12 mRNA therapy in orthotopic pancreatic ductal adenocarcinoma","volume":"381","author":"Shen","year":"2025","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.mtbio.2026.103568_bib203","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2025.166411","article-title":"Endocrine-driven FGF21 mRNA therapy via route-adaptable lipopolymer nanoparticles for the treatment of pancreatitis","volume":"520","author":"Liu","year":"2025","journal-title":"Chem. Eng. J."},{"issue":"6","key":"10.1016\/j.mtbio.2026.103568_bib225","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1021\/acs.jproteome.5b00213","article-title":"A comparison of the mouse and human lipoproteome: suitability of the mouse model for studies of human lipoproteins","volume":"14","author":"Gordon","year":"2015","journal-title":"J. Proteome Res."},{"issue":"12","key":"10.1016\/j.mtbio.2026.103568_bib226","doi-asserted-by":"crossref","first-page":"5511","DOI":"10.1021\/acs.jproteome.4c00653","article-title":"Distinct O-Acetylation patterns of serum glycoproteins among humans, mice, and rats","volume":"23","author":"Liu","year":"2024","journal-title":"J. Proteome Res."},{"issue":"1","key":"10.1016\/j.mtbio.2026.103568_bib227","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-23706-4","article-title":"Sex- and strain-differential plasma proteomic signatures in C57BL\/6 and BALB\/c mice","volume":"15","author":"Suh","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.mtbio.2026.103568_bib228","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1695213","article-title":"Exploring the impact of age, sex and life experiences on plasma inflammatory profiles through comparative proteomics","volume":"16","author":"Bartolucci","year":"2026","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.mtbio.2026.103568_bib229","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ymeth.2013.07.005","article-title":"Humanized FcRn mouse models for evaluating pharmacokinetics of human IgG antibodies","volume":"65","author":"Proetzel","year":"2014","journal-title":"Methods"},{"issue":"8","key":"10.1016\/j.mtbio.2026.103568_bib230","doi-asserted-by":"crossref","first-page":"4587","DOI":"10.1021\/acs.molpharmaceut.5c00068","article-title":"Surface plasmon resonance based binding characterization for screening RNA-loaded lipid nanoparticles (LNPs): exploring species cross-reactivity in LNP\u2013apolipoprotein E interactions","volume":"22","author":"Lew","year":"2025","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.mtbio.2026.103568_bib231","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2025.125282","article-title":"Glucocorticoid pre-administration improves LNP-mRNA mediated protein replacement and genome editing therapies","volume":"672","author":"Li","year":"2025","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.mtbio.2026.103568_bib232","doi-asserted-by":"crossref","unstructured":"Y. Lee, M. Jeong, G. Lee, J. Park, H. Jung, S. Im, H. Lee, Development of lipid nanoparticle formulation for the repeated administration of mRNA therapeutics, Biomater. Res. 28 17.","DOI":"10.34133\/bmr.0017"},{"key":"10.1016\/j.mtbio.2026.103568_bib233","doi-asserted-by":"crossref","DOI":"10.1038\/mtna.2013.66","article-title":"Influence of polyethylene glycol lipid desorption rates on pharmacokinetics and pharmacodynamics of siRNA lipid nanoparticles","volume":"2","author":"Mui","year":"2013","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.mtbio.2026.103568_bib234","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.jconrel.2021.05.001","article-title":"Anti-PEG IgM production and accelerated blood clearance phenomenon after the administration of PEGylated exosomes in mice","volume":"334","author":"Emam","year":"2021","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.mtbio.2026.103568_bib235","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119792","article-title":"PEG shedding-rate-dependent blood clearance of PEGylated lipid nanoparticles in mice: Faster PEG shedding attenuates anti-PEG IgM production","volume":"588","author":"Suzuki","year":"2020","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.mtbio.2026.103568_bib236","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/s41541-023-00766-z","article-title":"Polyethylene glycol (PEG)-associated immune responses triggered by clinically relevant lipid nanoparticles in rats","volume":"8","author":"Wang","year":"2023","journal-title":"npj Vaccines"},{"issue":"12","key":"10.1016\/j.mtbio.2026.103568_bib237","doi-asserted-by":"crossref","first-page":"3396","DOI":"10.1039\/D5NH00230C","article-title":"Influence of hydrophilic polymers on the accelerated blood clearance of mRNA lipid nanoparticles upon repeated administration","volume":"10","author":"Hassanel","year":"2025","journal-title":"Nanoscale Horiz."},{"key":"10.1016\/j.mtbio.2026.103568_bib238","article-title":"Durable protective efficiency provide by mRNA vaccines require robust immune memory to antigens and weak immune memory to lipid nanoparticles","volume":"25","author":"Tang","year":"2024","journal-title":"Mater. Today Bio"},{"key":"10.1016\/j.mtbio.2026.103568_bib239","article-title":"\u201cY-type\u201d PEG modified liposomes could eliminate the accelerated blood clearance (ABC) phenomenon and improved tumor therapy","volume":"32","author":"Liu","year":"2023","journal-title":"Appl. Mater. Today"},{"issue":"2","key":"10.1016\/j.mtbio.2026.103568_bib240","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.xphs.2022.11.001","article-title":"The storage and In-Use stability of mRNA vaccines and therapeutics: not A cold case","volume":"112","author":"Oude Blenke","year":"2023","journal-title":"J. Pharmaceut. Sci."},{"issue":"19","key":"10.1016\/j.mtbio.2026.103568_bib241","doi-asserted-by":"crossref","DOI":"10.3390\/ijms251910603","article-title":"Comprehensive optimization of a freeze-drying process achieving enhanced long-term stability and in vivo performance of lyophilized mRNA-LNPs","volume":"25","author":"Alejo","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.mtbio.2026.103568_bib242","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.ejpb.2022.11.014","article-title":"SV-AUC as a stability-indicating method for the characterization of mRNA-LNPs","volume":"182","author":"Thaller","year":"2023","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.mtbio.2026.103568_bib243","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2025.126426","article-title":"Recent advances in freeze-drying technologies for mRNA vaccines against infectious diseases","volume":"687","author":"Lou","year":"2026","journal-title":"Int. J. Pharm."},{"issue":"3","key":"10.1016\/j.mtbio.2026.103568_bib244","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1007\/s11095-026-04039-x","article-title":"Freezing-induced stress in mRNA-Lipid nanoparticles during lyophilization: mechanistic insights from process and formulation studies","volume":"43","author":"Ruppl","year":"2026","journal-title":"Pharm. Res."},{"issue":"12","key":"10.1016\/j.mtbio.2026.103568_bib245","doi-asserted-by":"crossref","first-page":"4327","DOI":"10.1039\/D2BM02031A","article-title":"Successful batch and continuous lyophilization of mRNA LNP formulations depend on cryoprotectants and ionizable lipids","volume":"11","author":"Lamoot","year":"2023","journal-title":"Biomater. Sci."},{"issue":"3","key":"10.1016\/j.mtbio.2026.103568_bib246","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2025.102686","article-title":"Pharmacometric modeling of lipid nanoparticle-encapsulated mRNA therapeutics and vaccines: a systematic review","volume":"36","author":"Zhang","year":"2025","journal-title":"Mol. Ther. Nucleic Acids"},{"issue":"5","key":"10.1016\/j.mtbio.2026.103568_bib247","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1016\/j.ymthe.2022.02.001","article-title":"Lyophilization provides long-term stability for a lipid nanoparticle-formulated, nucleoside-modified mRNA vaccine","volume":"30","author":"Muramatsu","year":"2022","journal-title":"Mol. Ther."},{"key":"10.1016\/j.mtbio.2026.103568_bib248","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2026.114749","article-title":"A functional lyoprotectant platform enables storage-stable, mucus-penetrating siRNA delivery to the lung","volume":"393","author":"Sun","year":"2026","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.mtbio.2026.103568_bib249","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jconrel.2023.03.039","article-title":"Continuous freeze-drying of messenger RNA lipid nanoparticles enables storage at higher temperatures","volume":"357","author":"Meulewaeter","year":"2023","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.mtbio.2026.103568_bib250","article-title":"Design, optimization, and evaluation of lyophilized lipid nanoparticles for mRNA-based pulmonary mucosal vaccination","volume":"32","author":"Lu","year":"2025","journal-title":"Mater. Today Bio"},{"issue":"48","key":"10.1016\/j.mtbio.2026.103568_bib251","doi-asserted-by":"crossref","first-page":"40279","DOI":"10.1039\/D5RA05353F","article-title":"Influence of polyethylene glycol on the mucus penetration and stability of lipid nanoparticles in cryopreservation and lyophilization","volume":"15","author":"Wang","year":"2025","journal-title":"RSC Adv."},{"key":"10.1016\/j.mtbio.2026.103568_bib252","doi-asserted-by":"crossref","first-page":"512","DOI":"10.3390\/pharmaceutics14030512","article-title":"Nonviral delivery systems of mRNA vaccines for cancer gene therapy","author":"Wang","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.mtbio.2026.103568_bib253","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.124686","article-title":"The piper at the gates of brain: a systematic review of surface modification strategies on lipid nanoparticles to overcome the blood-brain-barrier","volume":"665","author":"Vargas","year":"2024","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.mtbio.2026.103568_bib254","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/s41541-025-01124-x","article-title":"Ionizable lipid nanoparticles of mRNA vaccines elicit NF-\u03baB and IRF responses through toll-like receptor 4","volume":"10","author":"Zelkoski","year":"2025","journal-title":"npj Vaccines"},{"issue":"8","key":"10.1016\/j.mtbio.2026.103568_bib255","doi-asserted-by":"crossref","first-page":"7572","DOI":"10.1021\/acsnano.7b04734","article-title":"Next-generation lipids in RNA interference therapeutics","volume":"11","author":"Rietwyk","year":"2017","journal-title":"ACS Nano"},{"issue":"11","key":"10.1016\/j.mtbio.2026.103568_bib256","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.3390\/pharmaceutics14112357","article-title":"Stability study of mRNA-Lipid nanoparticles exposed to various conditions based on the evaluation between physicochemical properties and their relation with protein expression ability","volume":"14","author":"Kamiya","year":"2022","journal-title":"Pharmaceutics"},{"issue":"5","key":"10.1016\/j.mtbio.2026.103568_bib257","doi-asserted-by":"crossref","first-page":"566","DOI":"10.3390\/pharmaceutics17050566","article-title":"Low-cost microfluidic mixers: are they up to the task?","volume":"17","author":"Forrester","year":"2025","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.mtbio.2026.103568_bib258","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.jconrel.2021.11.042","article-title":"Anti-PEG antibodies compromise the integrity of PEGylated lipid-based nanoparticles via complement","volume":"341","author":"Estap\u00e9 Senti","year":"2022","journal-title":"J. Contr. Release"},{"issue":"23","key":"10.1016\/j.mtbio.2026.103568_bib259","doi-asserted-by":"crossref","first-page":"4535","DOI":"10.1039\/D4CC06659F","article-title":"The time course of in vivo cellular responses to LNPs\u2020\u2020Electronic supplementary information (ESI) available. S","volume":"61","author":"Loughrey","year":"2025","journal-title":"Chem. Commun."},{"issue":"8","key":"10.1016\/j.mtbio.2026.103568_bib260","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1039\/D5LC01130B","article-title":"Vertical numbering-up microfluidic architecture for scalable and homogeneous lipid nanoparticle production","volume":"26","author":"Zhang","year":"2026","journal-title":"Lab Chip"},{"key":"10.1016\/j.mtbio.2026.103568_bib261","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.jconrel.2024.07.021","article-title":"Rational formulation and industrial manufacturing of lipid-based complex injectables: landmarks and trends","volume":"373","author":"Biscaia-Caleiras","year":"2024","journal-title":"J. Contr. Release"}],"container-title":["Materials Today Bio"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590006426008136?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590006426008136?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T11:23:50Z","timestamp":1790335430000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590006426008136"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":261,"alternative-id":["S2590006426008136"],"URL":"https:\/\/doi.org\/10.1016\/j.mtbio.2026.103568","relation":{},"ISSN":["2590-0064"],"issn-type":[{"value":"2590-0064","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Overcoming hepatic tropism: Precision engineering of lipid nanoparticles for extrahepatic RNA delivery","name":"articletitle","label":"Article Title"},{"value":"Materials Today Bio","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mtbio.2026.103568","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"103568"}}